Alcohol-use disorders (Q83235766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19168210%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Alcohol-use disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19168210%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Marc A Schuckit

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19168210%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

23 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19168210%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19168210%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19168210%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

9662

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19168210%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

492-501

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19168210%20AND%20SRC:MED&resulttype=core&format=json

Substance use, dependence and treatment seeking in the United States and Australia: a cross-national comparison

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Alcohol, Europe and the developing countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Recovery from DSM-IV alcohol dependence: United States, 2001-2002

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Prospective evaluation of the four DSM-IV criteria for alcohol abuse in a large population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Nosological comparisons of alcohol and drug diagnoses: a multisite, multi-instrument international study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Validity of the CAGE questionnaire in an American Indian population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The alcohol use disorders identification test: an update of research findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The alcohol use disorders identification test for detecting at-risk drinking: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Diagnosis and management of alcohol use disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Use of laboratory tests to monitor heavy drinking by alcoholic men discharged from a treatment program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Dose-effect relation between daily ethanol intake in the range 0-70 grams and %CDT value: validation of a cut-off value.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Distribution and dose response of laboratory markers to alcohol consumption in a general population: results of the study of health in Pomerania (SHIP).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Biomarkers in alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Alcohol-induced liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The long-term course of alcoholism, 5, 10 and 16 years after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Externalizing disorders in the offspring from the San Diego prospective study of alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Relationship of age of first drink to child behavioral problems and family psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The natural history of adolescent alcohol use disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Comorbidity between substance use disorders and psychiatric conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The biological bases of nicotine and alcohol co-addiction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Do smokers with alcohol problems have more difficulty quitting?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Drinking in the year after treatment as a predictor of three-year drinking outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Predictors of abstinence and nonproblem drinking after 12-step treatment in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

United Kingdom and United States healthcare providers' recommendations of abstinence versus controlled drinking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Rates and predictors of relapse after natural and treated remission from alcohol use disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Stability of remission from alcohol dependence without formal help

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Per capita alcohol consumption and all-cause mortality in Canada, 1950-98.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Mortality attributable to harmful drinking in the United States, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

An evaluation of the level of response to alcohol, externalizing symptoms, and depressive symptoms as predictors of alcoholism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

College attendance and its effect on drinking behaviors in a longitudinal study of adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Seeking the connections: alcoholism and our genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Associations of ALDH2 and ADH1B genotypes with response to alcohol in Asian Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

A joint genomewide linkage analysis of symptoms of alcohol dependence and conduct disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The role of GABRA2 in risk for conduct disorder and alcohol and drug dependence across developmental stages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

A cholinergic receptor gene (CHRM2) affects event-related oscillations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Novelty seeking involved in mediating the association between the dopamine D4 receptor gene exon III polymorphism and heavy drinking in male adolescents: results from a high-risk community sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Low level of response to alcohol as associated with serotonin transporter genotype and high alcohol intake in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The search for genes contributing to the low level of response to alcohol: patterns of findings across studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Associations of variations in alcohol dehydrogenase genes with the level of response to alcohol in non-Asians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Effects of Variation at the ALDH2 Locus on Alcohol Metabolism, Sensitivity, Consumption, and Dependence in Europeans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Dimensional anxiety mediates linkage of GABRA2 haplotypes with alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The NMDA receptor system: genetic risk factor for alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The neural basis of addiction: a pathology of motivation and choice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The role of opioid receptor subtypes in the development of behavioral sensitization to ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Serotonin transporter gene variation is associated with alcohol sensitivity in rhesus macaques exposed to early-life stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

There and back again: a tale of norepinephrine and drug addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Role of endocannabinoids in alcohol consumption and intoxication: studies of mice lacking fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Acetylcholine and alcohol sensitivity of neuronal nicotinic acetylcholine receptors: mutations in transmembrane domains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Lapses following alcohol treatment: modeling the falls from the wagon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The natural history and pathophysiology of Wernicke's Encephalopathy and Korsakoff's Psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Genetic epidemiology of alcohol-induced blackouts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Genuine episodic memory deficits and executive dysfunctions in alcoholic subjects early in abstinence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Manifestations of early brain recovery associated with abstinence from alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Effects of alcohol on sleep and the sleep electroencephalogram in healthy young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Perception of sleep in recovering alcohol-dependent patients with insomnia: relationship with future drinking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Treatment of alcoholic polyneuropathy with vitamin B complex: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Up-regulation of myocardial L-type Ca2+ channel in chronic alcoholic subjects without cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Acute alcohol intake and QT dispersion in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Recent trends in incidence rates for selected alcohol-related cancers in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Alcohol and pancreatitis mortality at the population level: experiences from 14 western countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Could the high level of cirrhosis in central and eastern Europe be due partly to the quality of alcohol consumed? An exploratory investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Acute alcohol use among patients with acute hip fractures: a descriptive incidence study in southeastern Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Red blood cells (RBC) deformability and aggregability: alterations in alcoholism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

In Utero Alcohol Exposure and Prediction of Alcohol Disorders in Early Adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Letter and category fluency in children with fetal alcohol syndrome from a community in South Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Patterns of health services use associated with Veterans Affairs outpatient substance-use treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Impact of a stimulant-focused enhanced program on the outcome of alcohol- and/or stimulant-dependent men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Outpatient alcoholism treatment: predictors of outcome after 3 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Predictors of outcome for patients with substance-use disorders five years after treatment dropout.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

A randomized controlled trial of Moderation-Oriented Cue Exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Screening and referral for brief intervention of alcohol-misusing patients in an emergency department: a pragmatic randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Brief physician advice for problem drinking among older adults: an economic analysis of costs and benefits.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

BRIEF INTERVENTIONS FOR AT-RISK DRINKING: PATIENT OUTCOMES AND COST-EFFECTIVENESS IN MANAGED CARE ORGANIZATIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Two-year outcome of alcohol interventions in Swedish university halls of residence: a cluster randomized trial of a brief skills training program, twelve-step-influenced intervention, and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Process evaluation of an out-patient detoxification service

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Routine hospital alcohol detoxification practice compared to symptom triggered management with an Objective Withdrawal Scale (CIWA-Ar).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Relapse prevention for alcohol and drug problems: that was Zen, this is Tao.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Inpatient substance abuse care and the outcome of subsequent community residential and outpatient care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Advances in the pharmacotherapy of alcoholism: challenging misconceptions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The status of disulfiram: a half of a century later

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Does disulfiram have a role in alcoholism treatment today?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Follow-up of 180 Alcoholic Patients for up to 7 Years After Outpatient Treatment: Impact of Alcohol Deterrents on Outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: is there still a role for these drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Refractive hypotension in a patient with disulfiram-ethanol reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Understanding and treating alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

Topiramate for treating alcohol dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960009-X

7 January 2021

10.1016/S0140-6736(09)60009-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19168210%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference